Retrospective analysis of real-world use of cefiderocol for the treatment of Gram-negative infections as part of the early access program (PERSEUS study)
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: SHIONOGI SL
- Execution start: 09/02/2023
- End of execution: 30/06/2023
- PI: CARMEN HIDALGO TENORIO
